Precursor for radiolabelled TETA-Octreotide
TETA-Octreotide; TETA-OC; CA index name: L-Cysteinamide, N-[[4,8,11-tris(carboxymethyl)-1,4,8,11-tetraazacyclotetradec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-phenylalanyl- D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
Sequence: TETA-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol), cyclic disulfide; TETA = (4,8,11-Triscarboxymethyl-1,4,8,11-tetraaza-cyclotetradec-1-yl)-acetyl; Supplied as acetate salt
Molar mass 1433.70
CAS RN [226084-96-4] (net peptide)
Purity ≥ 97 %
- Colorless to off-white freeze-dried solid
CoA: appearance, MS (identity), HPLC (purity)
Anderson C.J. et al. ⁶⁴Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med. 2001, 42, 213–21.
Lewis J.S. et al. Radiotherapy and dosimetry of ⁶⁴Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model. Clin Cancer Res. 1999, 5, 3608–16.
Anderson C.J. et al. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. J Nucl Med. 1998, 39, 1944–51.
Add to inquiry
|Product||Product No.||Filling amount||Quantity|
|/products/chemicals/chemical/9b4cb6dd-d61b-4d99-ac9c-35cc6316e483||Precursor||Product No.: 9760||Filling amount: 1 mg|
|/products/chemicals/chemical/9b4cb6dd-d61b-4d99-ac9c-35cc6316e483||Precursor||Product No.: 9760||Filling amount: 10 mg|
|/products/chemicals/chemical/9b4cb6dd-d61b-4d99-ac9c-35cc6316e483||Precursor||Product No.: 9760|